The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will ...
Cellink AB (publ) (STO:CLNK B) shareholders might be concerned after seeing the share price drop 14% in the last quarter. But looking back over the last year, the returns have actually been rather ...
One day we’ll replace our old knackered organs with brand new ones that are printed out exclusively for us with a 3D printer. And when we do, we’ll quite possibly use a printer like the Cellink Bio X ...
Stockholm, April 20, 2020 – Nasdaq (Nasdaq: NDAQ) announces that the trading in Cellink AB’s shares (short name: CLNK B) will commence today on the Nasdaq Stockholm main market. Cellink belongs to the ...
CELLINK today announced its partnership with Made In Space, Inc. (MIS), the industry leader for space manufacturing technologies, to develop advanced bioprinting technology for space. The partnership ...
The recent breakthrough in harvesting pig organs for mammalian heart transplants has put the spotlight back on the efforts of many researchers around the world to help solve the world’s organ shortage ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The $130 million building ...
CELLINK has launched the next part of a multiphase bioink expansion. This phase includes the release of two new bioink series, the expansion of three existing bioink series, the release of a new ...
CELLINK has been granted a patent for a unique cellulose-based bioink technology enabling bioprinting of multiple cell types for cell culturing, tissue engineering and regenerative medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results